Many studies have demonstrated that RPLP2 is highly expressed and associated with poor prognosis in various cancer types such as, breast, colon and lung cancers, and it may involve in carcinogens by affecting the translation of specific cellular mRNAs [17–20]. The gene discussed is RPLP2; the disease is lung carcinoma.